MBIO Mustang Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MBIO

Price (delayed)

$1.42

Market cap

$13.09M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$7.99

Enterprise value

$5.35M

Mustang Bio, Inc. ("Mustang") is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare ...

Highlights
The company's debt has shrunk by 92% YoY and by 2.8% QoQ
MBIO's EPS is up by 27% year-on-year and by 13% since the previous quarter
MBIO's equity has dropped by 94% year-on-year and by 71% since the previous quarter
The quick ratio has shrunk by 89% YoY and by 42% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.mustangbio.com
Peers: OMGA

Key stats

What are the main financial stats of MBIO
Market
Shares outstanding
9.22M
Market cap
$13.09M
Enterprise value
$5.35M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.91
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$57.35M
EBITDA
-$54.65M
Free cash flow
-$51.64M
Per share
EPS
-$7.99
Free cash flow per share
-$6.32
Book value per share
$0.49
Revenue per share
$0
TBVPS
$2.52
Balance sheet
Total assets
$20.57M
Total liabilities
$16.56M
Debt
$2.58M
Equity
$4.01M
Working capital
-$578,000
Liquidity
Debt to equity
0.64
Current ratio
0.96
Quick ratio
0.73
Net debt/EBITDA
0.14
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-116.1%
Return on equity
-267%
Return on invested capital
-342.3%
Return on capital employed
-895.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MBIO stock price

How has the Mustang Bio stock price performed over time
Intraday
-2.02%
1 week
-8.97%
1 month
-5.33%
1 year
-98.67%
YTD
-98.4%
QTD
-31.4%

Financial performance

How have Mustang Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$59.95M
Net income
-$62.62M
Gross margin
N/A
Net margin
N/A
MBIO's operating income is up by 22% YoY and by 12% from the previous quarter
MBIO's net income is up by 20% year-on-year and by 12% since the previous quarter

Growth

What is Mustang Bio's growth rate over time

Valuation

What is Mustang Bio stock price valuation
P/E
N/A
P/B
2.91
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
MBIO's EPS is up by 27% year-on-year and by 13% since the previous quarter
MBIO's equity has dropped by 94% year-on-year and by 71% since the previous quarter
The P/B is 39% above the 5-year quarterly average of 2.1 and 12% above the last 4 quarters average of 2.6

Efficiency

How efficient is Mustang Bio business performance
MBIO's ROA has plunged by 83% YoY and by 23% from the previous quarter
The company's return on equity fell by 44% QoQ
The ROIC has decreased by 34% from the previous quarter and by 17% YoY

Dividends

What is MBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MBIO.

Financial health

How did Mustang Bio financials performed over time
Mustang Bio's total assets is 24% more than its total liabilities
The quick ratio has shrunk by 89% YoY and by 42% QoQ
Mustang Bio's current ratio has shrunk by 86% YoY and by 45% QoQ
The company's debt is 36% lower than its equity
MBIO's equity has dropped by 94% year-on-year and by 71% since the previous quarter
The company's debt has shrunk by 92% YoY and by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.